CD274 and carcinoma of esophagus: Among these, PD-L1 expression on TAMs could offer a prognostic biomarker for esophageal carcinoma [79], suggesting that expression of PD-L1 on TAMs might provide a predictive biomarker for anti-PD1 Ab therapy.